SUPPLY OF CATHETERIZATION LABORATORY (CATH LAB) CONSUMABLES
Solicitation number PHSA 04062
Publication date
Closing date and time 2022/10/31 15:00 EDT
Last amendment date
Description
RFP Objective:
This RFP is being issued to identify one or multiple Proponents to enter into non-exclusive Contract(s) between a Proponent and the Health Authorities, through Provincial Health Services Authority (“PHSA”) acting on its own behalf and as agent for other Health Authorities, for the supply of the Cardiac Catheterization Laboratory (Cath Lab) Consumables described in Appendix J (Pricing) and/or Services described herein to the Health Authorities at their facilities listed in Appendix B (List of Participating Health Authority Facilities).
Any Contract resulting from this RFP may be executed by PHSA on its own behalf and in its capacity as an agent for other Health Authorities.
Scope:
PHSA invites Proposals from qualified parties for the supply of the Products to the Health Authorities in accordance with the specifications and requirements set out in this RFP.
The Products Categories are identified in Appendix J (Pricing). These include the following list of Product categories and sub-categories:
Proponents should provide fixed pricing for a Contract term of three (3) years plus two (2) x one (1) year extensions as permitted under the Contract. Proponents should identify the components of the Products included in the base price, all consumable products, and substitute consumable products including any conditions relevant to the supply of such products.
For the Product, subcategories of Drug Eluting Stents and Balloon Catheters proponents should provide pricing for a potential market share award of the total provincial consumption for these subcategories of either sixty (60) percent or thirty (30) percent. Ten (10) percent of market share will be left un-awarded to allow access to other Products that become available during the term of the Contract.
The historical consumption for 2021 was 15,223 stents used in 8,297 cases. Future consumption is estimated based on historical consumption but it depends on funding and resource availability. At this time, we are not expecting significant changes in case volume.
This RFP is being issued to identify one or multiple Proponents to enter into non-exclusive Contract(s) between a Proponent and the Health Authorities, through Provincial Health Services Authority (“PHSA”) acting on its own behalf and as agent for other Health Authorities, for the supply of the Cardiac Catheterization Laboratory (Cath Lab) Consumables described in Appendix J (Pricing) and/or Services described herein to the Health Authorities at their facilities listed in Appendix B (List of Participating Health Authority Facilities).
Any Contract resulting from this RFP may be executed by PHSA on its own behalf and in its capacity as an agent for other Health Authorities.
Scope:
PHSA invites Proposals from qualified parties for the supply of the Products to the Health Authorities in accordance with the specifications and requirements set out in this RFP.
The Products Categories are identified in Appendix J (Pricing). These include the following list of Product categories and sub-categories:
| Complex PCI | PCI Guidance | Structural Heart |
| Guidewire | Guidance System | Covered Stent |
| Vascular Closure | Pressure Wires | Delivery System |
| Inflation Device | Imaging Catheter | LAA |
| Guiding Catheter | ASD | |
| Drug Eluting Stents | PDA | |
| Diagnostic Catheters | PFO | |
| Bare Metal Stents | Sizing Balloon | |
| Balloon Dilation Catheters | Septal | |
| Cutting Balloon Catheters | ||
| Introducer Sheath | ||
| Extraction Catheter | ||
| Rotablator | ||
| Accessory Kit | ||
| Accessory | ||
| Vascular Plug |
Proponents should provide fixed pricing for a Contract term of three (3) years plus two (2) x one (1) year extensions as permitted under the Contract. Proponents should identify the components of the Products included in the base price, all consumable products, and substitute consumable products including any conditions relevant to the supply of such products.
For the Product, subcategories of Drug Eluting Stents and Balloon Catheters proponents should provide pricing for a potential market share award of the total provincial consumption for these subcategories of either sixty (60) percent or thirty (30) percent. Ten (10) percent of market share will be left un-awarded to allow access to other Products that become available during the term of the Contract.
The historical consumption for 2021 was 15,223 stents used in 8,297 cases. Future consumption is estimated based on historical consumption but it depends on funding and resource availability. At this time, we are not expecting significant changes in case volume.
Contract duration
Refer to the description above for full details.
Trade agreements
-
Please refer to tender description or tender documents
Contact information
Contracting organization
- Organization
-
Provincial Health Services Authority (Incl. BCCSS)
- Email
- ali.Sipra@phsa.ca
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.